FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to oncoimmunology, and aims at determining autologous anticancer activity of blood neutrophils in oncological diseases. Blood and tumor tissues are taken in the patients, blood chemistry is used to determine an autologous anti-tumor activity index of neutrophils (AAAIN). If AAAIN is 2.0 or less, high level of anti-tumor activity of neutrophils to autologous tumor cells is determined in patients with oncological diseases. If AAAIN is more than 2.0, low autologous antineoplastic activity of neutrophils is determined.
EFFECT: invention enables determining the level of autologous anticancer activity of blood neutrophils in the patients with oncological diseases.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INCREASING THE AUTOLOGOUS ANTITUMOUR ACTIVITY OF NEUTROPHILS IN VITRO | 2020 |
|
RU2762852C1 |
| METHOD FOR INDIVIDUALLY SELECTING AND ADJUSTING INTERFERON DOSE IN RENAL CARCINOMA PATIENTS | 2005 |
|
RU2314123C2 |
| METHOD OF PRODUCING AUTOLOGOUS DENDRITIC CELLS WITH HIGH LEVEL OF EXPRESSION OF HLA-DR AND COSTIMULATORY MOLECULES IN ONCOLOGICAL DISEASES | 2020 |
|
RU2767631C1 |
| METHOD FOR PREDICTING EARLY STAGE PYOSEPTIC POSTOPERATIVE COMPLICATIONS IN RENAL CELLULAR CANCER PATIENTS | 2004 |
|
RU2279082C2 |
| METHOD FOR ABDOMINAL SEPSIS DEVELOPMENT PREDICTION IN PATIENTS WITH ADVANCED PYOPERITONITIS | 2015 |
|
RU2620560C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN ACUTE RHINOSINUSITIS | 2010 |
|
RU2438134C1 |
| METHOD FOR PREDICTION OF INTERFERON SENSITIVITY IN PATIENTS SUFFERING RENAL CELL CARCINOMA | 2010 |
|
RU2437101C1 |
| METHOD FOR ESTIMATING RENAL CARCINOMA PATIENT SENSITIVITY TO INTERFERON | 2005 |
|
RU2293988C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF RECURRENCE OF DIFFUSE LARGE B-CELL LYMPHOMA | 2021 |
|
RU2758126C1 |
| METHOD FOR INDIVIDUAL PRESCRIPTION OF IMMUNOACTIVE PREPARATIONS IN TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2011 |
|
RU2480760C2 |
